BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 9717332)

  • 21. Inner-ear obliteration in ulcerative colitis patients with sensorineural hearing loss.
    Kariya S; Fukushima K; Kataoka Y; Tominaga S; Nishizaki K
    J Laryngol Otol; 2008 Aug; 122(8):871-4. PubMed ID: 18086336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laser applications in inner ear surgery.
    Anthony PF
    Otolaryngol Clin North Am; 1996 Dec; 29(6):1031-48. PubMed ID: 8890133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Otologic diagnosis and the treatment of deafness.
    Myers D; Schlosser WD; Wolfson RJ; Winchester RA; Carmel NH
    Clin Symp; 1970; 22(2):35-69. PubMed ID: 4915753
    [No Abstract]   [Full Text] [Related]  

  • 24. A surgical solution for the difficult chronic ear.
    Jackson CG; Schall DG; Glasscock ME; Macias JD; Widick MH; Touma BJ
    Am J Otol; 1996 Jan; 17(1):7-14. PubMed ID: 8694138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unilateral sensorineural hearing loss after spine surgery: Case report and review of the literature.
    Park P; Toung JS; Smythe P; Telian SA; La Marca F
    Surg Neurol; 2006 Oct; 66(4):415-8; discussion 418-9. PubMed ID: 17015127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State of the art on the development of the implantable hearing device for partial hearing loss.
    Maniglia AJ
    Otolaryngol Clin North Am; 1996 Apr; 29(2):225-43. PubMed ID: 8860922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune-mediated sensorineural hearing loss: prevalence and treatment strategies].
    Li X; Chen Y; Zhang G; Cui W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jul; 34(7):663-667. PubMed ID: 32791649
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunity and autoimmunity. With special reference to inner ear diseases.
    Melchers F
    Adv Otorhinolaryngol; 1991; 46():17-25. PubMed ID: 1927716
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in translational inner ear stem cell research.
    Warnecke A; Mellott AJ; Römer A; Lenarz T; Staecker H
    Hear Res; 2017 Sep; 353():76-86. PubMed ID: 28571616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of fenestration in congenital ear surgery.
    Schwaber MK; Glasscock ME; Nissen AJ; Jackson CG
    Am J Otol; 1983 Jan; 4(3):222-5. PubMed ID: 6338729
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholesteatoma of the kidney--update].
    Gruenwald I; Lurie A
    Harefuah; 1994 Jan; 126(1):35-7. PubMed ID: 8138205
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preservation of hearing in labyrinthectomies for cholesteatoma].
    Ramírez Camacho R; Trinidad A; Vicente J; García Berrocal JR
    Acta Otorrinolaringol Esp; 1998; 49(5):404-7. PubMed ID: 9717332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preservation of hearing in cholesteatomas with inner ear invasion.
    Canalis RF; Abemayor E; McClean P
    J Otolaryngol; 1989 Dec; 18(7):374-9. PubMed ID: 2687485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of cochlear function after extensive labyrinthine destruction.
    Ars B; Claes J; Casselman J; Ars-Piret N
    Am J Otol; 1996 Jan; 17(1):40-5. PubMed ID: 8694133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of labyrinthine fistulas in cholesteatoma.
    Vanden Abeele D; Offeciers FE
    Acta Otorhinolaryngol Belg; 1993; 47(3):311-21. PubMed ID: 8213141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing and vertigo outcomes after congenital labyrinthine cholesteatoma resection.
    Liu YC; Semaan MT; Rayess H; Megerian CA
    Am J Otolaryngol; 2014; 35(3):417-23. PubMed ID: 24503247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.